Biospectra: Reshoring and Onshoring Premium Pharmaceutical Products for over 25 Years

Date Published08/22/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name BioSpectra
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):100
Year reshoring announced:2020
Year reshoring implemented or to be implemented:1995
Domestically, the work will be done:In-house
City reshored to:Bangor
State(s) reshored to:PA
If relevant, work nearshored to:-
Product(s) reshoredpharmaceutical ingredients
What non-domestic negative factors made offshoring less attractive?Intellectual property risk, Quality/rework/warranty, Social/ethical concerns, Supply chain interruption risk/Natural disaster risk/Political instability
What domestic positive factors made reshoring more attractive?Impact on domestic economy, Lead time/Time to market, Skilled workforce availability/training
Find Reshoring Articles